Canada markets open in 2 hours 40 minutes

Microbix Biosystems Inc. (MBX.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
0.7100+0.0200 (+2.90%)
At close: 03:40PM EST
Currency in CAD

Valuation Measures4

Market Cap (intraday) 96.18M
Enterprise Value 93.92M
Trailing P/E 28.46
Forward P/E 18.48
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)5.64
Price/Book (mrq)5.18
Enterprise Value/Revenue 5.05
Enterprise Value/EBITDA 16.60

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 339.22%
S&P500 52-Week Change 316.48%
52 Week High 30.8700
52 Week Low 30.4400
50-Day Moving Average 30.7300
200-Day Moving Average 30.6441

Share Statistics

Avg Vol (3 month) 386.61k
Avg Vol (10 day) 381.61k
Shares Outstanding 5129.97M
Implied Shares Outstanding 6N/A
Float 8111.51M
% Held by Insiders 110.48%
% Held by Institutions 12.18%
Shares Short (Jan. 13, 2022) 48.44k
Short Ratio (Jan. 13, 2022) 40.08
Short % of Float (Jan. 13, 2022) 4N/A
Short % of Shares Outstanding (Jan. 13, 2022) 40.01%
Shares Short (prior month Dec. 14, 2021) 410.76k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Sep. 01, 1999
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Sep. 29, 2021
Most Recent Quarter (mrq)Sep. 29, 2021


Profit Margin 17.39%
Operating Margin (ttm)26.01%

Management Effectiveness

Return on Assets (ttm)13.61%
Return on Equity (ttm)25.69%

Income Statement

Revenue (ttm)18.59M
Revenue Per Share (ttm)0.16
Quarterly Revenue Growth (yoy)108.10%
Gross Profit (ttm)11.04M
Net Income Avi to Common (ttm)3.23M
Diluted EPS (ttm)0.0260
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.99M
Total Cash Per Share (mrq)0.08
Total Debt (mrq)7.74M
Total Debt/Equity (mrq)41.68
Current Ratio (mrq)3.68
Book Value Per Share (mrq)0.14

Cash Flow Statement

Operating Cash Flow (ttm)2.11M
Levered Free Cash Flow (ttm)-1.43M